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 2 
In humans, the endometrium, the uterine mucosal lining, undergoes dynamic 1 
changes throughout the menstrual cycle and pregnancy. Despite the 2 
importance of the endometrium as the site of implantation and nutritional 3 
support for the conceptus, there are no long-term culture systems that 4 
recapitulate endometrial function in vitro. We adapted conditions used to 5 
establish human adult stem cell-derived organoid cultures to generate 3D 6 
cultures of normal and decidualised human endometrium. These organoids 7 
expand long-term, are genetically stable and differentiate following treatment 8 
with reproductive hormones. Single cells from both endometrium and decidua 9 
can generate a fully functional organoid. Transcript analysis confirmed great 10 
similarity between organoids and the primary tissue of origin. On exposure to 11 
pregnancy signals, endometrial organoids develop characteristics of early 12 
pregnancy. We also derived organoids from malignant endometrium, and so 13 
provide a foundation to study common diseases, such as endometriosis and 14 
endometrial cancer, as well as the physiology of early gestation. 15 
 16 
Throughout adult reproductive life, the functional layer of the human endometrium 17 
undergoes a monthly cycle of regeneration, differentiation and shedding under the 18 
control of the hypothalamic-pituitary-ovarian (HPO) axis.  The mucosa contains 19 
simple glands lined by secretory columnar epithelium, separated by intervening 20 
stroma.  During the estrogen-dominated proliferative phase that follows 21 
menstruation, the mucosa regrows and then differentiates during the progesterone-22 
dominated secretory phase. Implantation occurs ~7 days post-ovulation onto the 23 
ciliated luminal epithelium and stimulates transformation into the gestational 24 
endometrium, the true decidua of pregnancy, that provides a microenvironment 25 
essential for placentation.  Up to ~10 weeks gestation, uterine glands provide 26 
histotrophic nutrition for the conceptus before the definitive hemochorial placenta is 27 
established1, 2. Animal models in mice and ruminants where glandular function is 28 
suppressed are unable to support implantation and pregnancy3, 4.  Such models 29 
have revealed the molecular interactions involved between the trophectoderm and 30 
the uterine surface and the key cytokines secreted by the glands, such as leukemia 31 
inhibitory factor5. However, the composition of the secretions, and the 32 
gland/conceptus signalling dialogue during human placentation are unknown due to 33 
their inaccessibility in vivo and the absence of in vitro models. Suboptimal glandular 34 
development and/or functions may result in human pregnancy failure or predispose 35 
to complications of later pregnancy, such as growth restriction6. Thus, model 36 
systems to study these essential processes of human early pregnancy would have 37 
many biological and clinical applications. 38 
Although stem/progenitor cells within the stromal compartment of the 39 
endometrium have been identified, suitable markers for glandular progenitors are 40 
unknown7. In mice, stem cells are probably present at the base of the glands8; 41 
similarly in primates, cells in the basal layer, that is not shed during menstruation, 42 
can generate both glandular and luminal epithelia9, 10. In humans, putative 43 
endometrial stem cells are the rare SSEA-1+, SOX9+ population with clonogenic 44 
ability11, 12 but these are not fully characterised and it is unknown how they maintain 45 
 3 
uterine glands. Previous culture systems of human endometrial glandular cells, 1 
including 3D cultures, do not fully recapitulate glandular features in vivo, and are not 2 
long-term or chemically defined13, 14. Establishing defined endometrial organoid 3 
cultures will offer possibilities for studying events during implantation and early 4 
pregnancy in vitro as human blastocysts can be cultured past the implantation phase 5 
of development15, 16.  6 
Organoids are self-organising, genetically stable, 3D culture systems 7 
containing both progenitor/stem and differentiated cells that resemble the tissue of 8 
origin. Human organoids have been derived from tissue-resident adult epithelial stem 9 
cells from gut, liver, pancreas, prostate and fallopian tube17-21. We have now 10 
generated long-term, chemically-defined 3D glandular organoid cultures from non-11 
pregnant endometrium and decidua.  The organoids recapitulate features of uterine 12 
glands in vivo; the ability to respond to hormonal signals, secrete components of 13 
uterine ‘milk’ and differentiate into ciliated luminal epithelial cells.  Human 14 
endometrial organoids can be used to answer questions about uterine/placental 15 
cross-talk during placentation, and will provide a system for studying the 16 
pathogenesis and treatment of common conditions affecting women, such as 17 
endometriosis and endometrial cancer. 18 
 19 
RESULTS 20 
 21 
Long-term genetically-stable 3D organoid cultures can be established from 22 
human non-pregnant endometrium and decidua.  23 
To generate endometrial organoids, we used tissue isolates enriched for epithelial 24 
cells, and allowed these to self-organise within Matrigel droplets with the basal 25 
medium that supports development of other human tissue organoids, containing 26 
EGF, Noggin and R-spondin-1 (ENR) (Fig. 1a). Because the signalling pathways 27 
maintaining endometrial gland stem/progenitor cells are unknown, we tested factors 28 
secreted by surrounding stromal cells, FGF10 and HGF22-25.  Nicotinamide and the 29 
Alk3/4/5 inhibitor, A83-01, that blocks the TGFβ pathway were added as they are 30 
crucial in the establishment and/or long-term culture of other human organoid 31 
systems18, 20, 26.  Decidual samples were initially used to optimise the culture 32 
conditions as they yield high cell numbers.  Glandular cells were cultured for 7 days 33 
and passaged at 1:3.  Organoid numbers were counted after another 7 days (Fig. 34 
1b,c). A83-01, FGF10 and HGF with EGF, Noggin, R-spondin-1 and nicotinamide, 35 
expansion medium (ExM), gave the highest yield of cells (Fig. 1c, C8). 36 
Organoid cultures were established in ExM within 1-2 passages (Fig. 1d).  To 37 
assess the requirement for each culture component, 5000 cells were plated from 38 
established cultures (grown for >4 passages) in the absence of each factor, and the 39 
number of spheroids present after one week counted.  Withdrawal of nicotinamide 40 
had the strongest effect, whilst the lack of Noggin, Rspondin-1, A83-01, EGF and 41 
HGF resulted in reduced numbers and/or smaller organoids (Fig. 1e, Supplementary 42 
Fig. 1a). FGF10 was maintained in the medium even though it had no effect on size 43 
or numbers of organoids (Fig. 1e), because it was important initially in establishing 44 
cultures and provides a physiological environment (Fig. 1b). ENR, A83-01 and 45 
 4 
nicotinamide will maintain established cultures, but were not tested in differentiation 1 
experiments and long-term culture (Supplementary Fig. 1b). Organoid cultures were 2 
robustly established from decidual samples in ExM from 25/26 donors (derivation 3 
efficiency of 96%).  Organoids were then successfully generated from non-pregnant 4 
secretory endometrium with 100% derivation efficiency (11/11) (Fig. 1f). Proliferative 5 
phase endometrium is infrequently sampled, but we did generate organoids from this 6 
phase (n=3) and from atrophic endometrium (n=1), demonstrating that our culture 7 
conditions can be used for tissue throughout the menstrual cycle, as well as 8 
pregnant and post-menopausal endometrium (Fig. 1f). The origin and 9 
characterization of established organoid cultures used for this study are summarized 10 
in Supplementary Table 1. 11 
The established organoids can be expanded at passage ratios of 1:2 or 1:3 12 
every 7-10 days for >6 months (reaching more than a 106-fold increase in the 13 
number of organoids).  Markers of glandular epithelium (MUC1, E-CADHERIN, CK7 14 
and EPCAM) are strongly expressed by the organoids (Fig. 1g,h,i). EPCAM and 15 
LAMININ are present at the baso-lateral membrane, showing epithelial polarity is 16 
intact (Fig. 1i). EdU pulse-labelling shows ~30% of cells are actively replicating (Fig. 17 
1i). The organoids form cystic structures lined by columnar epithelium with 18 
secretions visible in the lumen. Electron microscopy reveals a microvillous, 19 
pseudostratified columnar epithelium supported by amorphous basement membrane 20 
material with basally-located nuclei (Fig. 1j). The cytoplasm contains plentiful rough 21 
endoplasmic reticulum and Golgi bodies, numerous secretory vesicles, with evidence 22 
of secretory activity from the apical surface (Fig. 1k, arrowheads).  A major 23 
component of endometrial glandular secretions, glycogen, was visualized by vivid 24 
PAS staining (Fig. 1l). Thus, the appearances are highly similar to endometrial 25 
glands in vivo27.  26 
Next, the chromosomal stability of our endometrial organoids was checked by 27 
Comparative Genomic Hybridization (CGH) array. Genomic DNAs were compared 28 
between the patient and established organoid cultures at early passage (p) (2-4p) 29 
and between early and late cultures (8-15p) (Supplementary Fig. 1d-f). No significant 30 
DNA copy number abnormalities were identified during derivation or after continuous 31 
passaging for up to 5 months.  These organoids can be frozen, thawed and regrown, 32 
allowing bio-banking of human endometrial cultures. 33 
 34 
Established human endometrial gland organoids recapitulate molecular 35 
signature of glands in vivo. 36 
To assess the similarity between organoids and the tissue of origin, we analysed the 37 
global gene expression profiles from established organoid lines (n=7), initial 38 
glandular digests, and cultured stromal cells from the same biopsy. Staining for 39 
MUC1 (glands) and VIMENTIN (stroma) confirmed enrichment of glands in our 40 
isolates and the purity of stromal cultures (Supplementary Fig. 2a-d).  Hierarchical 41 
clustering analysis based on 15,475 probes (sd/mean >0.1) shows that the organoid 42 
cultures cluster more closely to glands than to stroma, confirming their glandular 43 
epithelial nature (Fig. 2a). 44 
 5 
To define an endometrial glandular genetic signature, we compared glands 1 
and organoids to stroma.  287 genes were commonly upregulated in organoids and 2 
glands compared to stroma with a fold change of ≥1.5 (p≤0.01) (Fig. 2b).  Gene 3 
ontology (GO) analysis shows enrichment for ‘epithelial identity’ and ‘glandular 4 
function’ (Fig. 2c,d).  Markers of epithelial cells (CDH1, CLDN10 and EPCAM), 5 
mucosal secretory cells (PAX8 and MUC1) and of uterine glandular products were all 6 
present (PAEP, KLK11 and MUC20) (Fig. 2e). Murine genes involved in endometrial 7 
glandular development and function (FoxA2, Sox17 and Klf5) also emerged4, 28-31. 8 
Using immunohistochemistry, we verified nuclear presence of FOXA2, SOX17 and 9 
PAX8 in all organoids and endometrial glandular cells throughout the cycle (Fig. 2f).  10 
Markers (PROM1, AXIN2 and LRIG1) common to other epithelial progenitor cells32, 33 11 
were found (Fig. 2e), but in endometrium LRIG1 transcripts are present in glands 12 
and luminal epithelium throughout the cycle and so their significance is uncertain 13 
(Fig. 2g, Supplementary Fig. 3a). Analysis of expression of other putative 14 
endometrial stem cell markers, AXIN2 and SSEA1 was inconclusive11. Although 15 
AXIN2 transcripts were found in glands in vivo, lack of a reliable antibody prevented 16 
further analysis (Supplementary Fig.3b). Only a few cells were SSEA-1+ in 17 
organoids, analysed by immunohistochemistry and flow cytometry (2-3%) and, after 18 
sorting SSEA-1+/- cells, organoids emerged from the SSEA-1-negative fraction 19 
(Supplementary Fig. 3c, d). Overall the gene signature of decidual organoids (n=6) is 20 
also very similar to non-pregnant endometrium (Supplementary Fig. 4a), with 21 
immunostaining of FOXA2, SOX17 and PAX8 and expression of LRIG1 uniformly 22 
similar to ex vivo decidual glands (Supplementary Fig. 4b,c).  23 
 Apart from shared gene sets between glands and organoids, there are also 24 
genes only expressed in glands (421/652) or organoids (286/484) (Supplementary 25 
Fig. 5). GO terms for glands describe stromal interactions (integrin binding and 26 
extracellular matrix structural constituents), all absent in vitro. For organoids, in vitro 27 
proliferation, (cell division and mitotic nuclear division) dominated. Thus, differential 28 
gene expression between gland samples and organoids reflects their contrasting 29 
microenvironments.  30 
A converse analysis to define a stromal cell signature (Supplementary Fig. 2e) 31 
revealed minimal contamination from endothelial cells (CD31 or CD34) or leukocytes 32 
(CD45). GO analysis showed ‘biological processes’ typical of fibroblasts and 33 
‘molecular functions’ (Supplementary Fig. 2f, g). Gene sets were enriched for stromal 34 
cell markers (THY1, NT5E and IFITM1)34, 35, extracellular matrix proteins (COL8A1, 35 
COL12A1, COL13A1 and LAMA1), and metalloproteinases (MMP11, MMP2, 36 
MMP12, MMP27, MMP3, TIMP2 and CTGF) (Supplementary Fig. 2e). Genes 37 
encoding for components of WNT (WNT2, WNT5A, RSPO3), BMP (BMP2, GREM1) 38 
and MAPK (FGF2) signalling pathways also emerged, pathways already identified 39 
from our culture conditions.  40 
 41 
Human endometrial gland organoids respond to sex hormones. 42 
Unlike other mucosal epithelia, the endometrium responds dramatically to ovarian 43 
hormones, estrogen (E2) and progesterone (P4), which regulate cyclical proliferation 44 
and differentiation of endometrial glands with concomitant dynamic temporal and 45 
 6 
spatial expression of their receptors, ERα and PR (Fig. 3a)36-38. Following 1 
menstruation, glands increase expression of ERα in response to rising E2 levels 2 
(proliferative phase).  After ovulation, ERα expression declines in the early secretory 3 
phase whereas PR is maintained until mid-secretory (LH+7), after which both ERα 4 
and PR expression disappears37.  5 
To mimic the response of the organoid cultures to hormones, we exposed 6 
organoids to E2 followed by P4 (Fig. 3b).  Under ExM conditions most cells show 7 
weak expression of ERα (ERαlow) with some ERαhigh (Fig. 3c, arrowheads) and 8 
ERαnegative cells (Fig. 3c, arrows) present. Although most organoids are PRnegative, a 9 
few cells are PRhigh; on serial sections these are also ERαhigh.  After exposure to E2 10 
and P4, high expression of both ERα and PR is seen in most organoids similar to the 11 
situation in vivo (Fig. 3c). Organoid cultures derived from decidua showed similar 12 
responses (Supplementary Figure 6a). 13 
We performed a microarray analysis of organoids in ExM, E2 alone or E2 and 14 
P4. Known genes upregulated by E2 and P4 in the mid-secretory phase 17βHSD2, 15 
PAEP, SPP1, LIF, IGFBP4, IGFBP5 and CYCLIN A1 were all upregulated in 16 
hormonally-treated organoids (Fig. 3d)39-42. This was confirmed for several genes 17 
using qRT-PCR (Fig. 3e) and at the protein level for PAEP and SPP1 (Fig. 3 f,g).  18 
We also confirmed that the addition of cyclic adenosine monophosphate (cAMP) to 19 
the differentiation medium, a component used typically in decidualization protocols, 20 
enhances the expression of differentiation markers shown by increased expression 21 
of PAEP and SPP1 (Supplementary Fig. 6b)43. 22 
Other hormonally-regulated endometrial genes emerged, including OLFM4, 23 
an intestinal stem cell marker44.  In ExM, organoid cells were OLFM4-negative but a 24 
subset became OLFM4-positive after E2 treatment, similar to the proliferative phase 25 
in vivo (Fig. 3h, arrows). Collagen 1A2 (COL1A2), chromogranin A (CHGA) and 26 
OVOL2 were also upregulated, whilst HES1 and SOX9 were downregulated.  In 27 
summary, the phenotypic response of glandular endometrial organoids to ovarian 28 
sex hormones is characteristic of the early-mid secretory phase.   29 
 30 
Signals from decidualised stroma and the placenta can further stimulate 31 
differentiation of human endometrial gland organoids. 32 
If implantation occurs, the endometrium forms the true decidua of pregnancy in 33 
response to P4; decidualized stromal cells characteristically secrete Prolactin (PRL) 34 
45 (Fig. 4a). Both PRL and signals from the conceptus are likely to stimulate uterine 35 
gland activity in early pregnancy (Fig. 4a)46, 47. To mimic pregnancy, we added 36 
placental hormones (Chorionic Gonadotropin, hCG and human Placental Lactogen, 37 
hPL) in combinations with PRL to ExM containing E2+P4+cAMP, referred to as 38 
Differentiation Medium (DM) (Fig. 4b).  39 
 The three hormones together stimulate maximal production of PAEP and a 40 
hypersecretory morphology characteristic of decidual glands in vivo (Fig. 4c). PRL 41 
has an additional effect by stimulating the formation of ciliated cells (identified by 42 
acetylated α-tubulin) (Fig. 4d). Similar findings were obtained using conditioned 43 
media from stromal cells decidualized in vitro for 10 days (Supplementary Figure 6c). 44 
As ciliated cells are only present in vivo in the uterine luminal epithelium and in 45 
 7 
superficial glands, the organoids are undergoing both glandular and luminal 1 
differentiation. 2 
SOX9, a marker of progenitor cells, is expressed in the base of endometrial 3 
glands in vivo and at high levels in the organoids11, 48, 49 but is absent from decidual 4 
glands in vivo. Organoids cultured with both ovarian and pregnancy hormones 5 
undergo differentiation as SOX9 was downregulated (Fig. 4e). Thus, appropriate 6 
hormonal stimulation induces organoids to acquire a decidual-like phenotype 7 
characteristic of early pregnancy. 8 
 9 
Human endometrial organoids have clonogenic ability and are bipotent 10 
To assess for stem cell activity, we measured clonogenic ability by plating single 11 
cells from established organoid cultures by limiting dilution; drops containing single 12 
cells were marked and followed by time-lapse photography. Some cells formed an 13 
entire organoid over 7-14 days; the rest either did not divide or formed small dying 14 
spheroids (Fig. 5a). The organoid-forming efficiency of these cells, was 2-4% with 15 
100 cells/drop and ~10-fold lower with 10 cells/drop (Supplementary Table 2). Single 16 
organoids can be expanded into clonal cultures and we now have grown 12 clonal 17 
lines from 5 independently-derived organoids (Fig. 5b). A single cell has bi-potent 18 
ability as it could generate the two main endometrial cell types: secretory (PAEP+) 19 
and ciliated (acetylated-α-tubulin+) cells (Fig. 5c). Formation of cilia was confirmed 20 
by EM (Fig. 5d).  21 
 22 
Organoid cultures can be derived from endometrial cancer 23 
Endometrial cancer is the commonest gynecological tumour. Organoids were 24 
derived from samples of tumours and the normal adjacent endometrium from post-25 
menopausal women (Fig. 6). The morphology of the organoids resembles the 26 
primary tumour (FIGO Grade I Endometrioid Carcinoma) showing pleomorphic cells 27 
with hyperchromatic nuclei and disorganised epithelium.  In places breaching of the 28 
basement membrane is obvious, and isolated cells are seen in the surrounding 29 
Matrigel. The organoids are positive for glandular markers such as MUC1 and 30 
SOX17, confirming their glandular origin. 31 
 32 
DISCUSSION 33 
Here, we describe a robust chemically-defined method for establishing genetically 34 
stable endometrial organoids from human non-pregnant endometrium and decidua 35 
that can be cultured long-term and recapitulate the molecular signature of 36 
endometrial glands in vivo.  Several murine genes important for glandular 37 
development and function (Foxa2, Klf5 and Sox17) are also expressed.  The 38 
organoids functionally respond to sex hormones, E2 and P4, and when further 39 
stimulated with pregnancy (hCG, hPL) and stromal cell (PRL) signals, acquire 40 
characteristics of gestational endometrium, synthesising abundant PAEP (glycodelin) 41 
and SPP1 (osteopontin).  PAEP and SPP1, components of glandular secretions, 42 
 8 
‘uterine milk’, provide histotrophic nutrition to trophoblast before the hemochorial 1 
placenta is established. 2 
 Clonal organoid cultures generated from a single cell contain cells with 3 
extensive proliferative capacity, and both ciliated and secretory cells. Their gene 4 
signature includes markers of epithelial stem cells, LRIG1, PROM1, AXIN2 and 5 
SOX9. Because we could generate SOX9-expressing organoids from non-6 
proliferative, SOX9-, differentiated secretory phase endometrium and decidua, the 7 
few SOX9+ cells present mainly in the basal layer might expand11. Alternatively, 8 
plasticity of endometrial cells allows SOX9-negative differentiated cells to self-renew 9 
and reacquire SOX9 expression in our cultures.  A similar reversion occurs in the 10 
liver, where non-Lgr5+ cells reacquire Lgr5 stem cell marker expression upon tissue 11 
injury50.   12 
 Although organoids have been established from human fallopian tube with 13 
differentiation into both ciliated and secretory cells, neither the dramatic cyclical 14 
changes in response to E2 and P4, nor the process of decidualization induced by 15 
pregnancy occurs in the fallopian tube, a mucosal surface contiguous to 16 
endometrium21. Furthermore, the crucial site of embryo attachment is the luminal 17 
surface of the endometrium.  18 
Endometrial organoids can be maintained and expanded in ExM, 19 
recapitulating pathways essential for culturing organoids from other organs - the 20 
FGF-MAPK, WNT-Rspondin, BMP-Noggin and TGFβ signalling pathways51.  The 21 
contribution of endometrial stromal cells to these signalling pathways is revealed 22 
from our microarray analysis showing stromal transcripts encoding Rspondin-1 and 23 
FGF2. Further refinement of the method to replace Matrigel with a chemically-24 
defined extracellular matrix would enhance the model in future52. The identity of the 25 
endometrial epithelial stem cells remains unknown although their presence is 26 
revealed by the long-term expansion and clonogenic activity of organoids, and we 27 
have defined the essential niche components for their maintenance.  28 
We also recapitulate the glandular cyclical changes during the menstrual 29 
cycle triggered by sequential secretion of ovarian hormones, E2 and P4.  30 
Endometrial organoids acquire a differentiated phenotype characteristic of the mid-31 
secretory phase, with upregulation of several genes (17βHSD2, SPP1, LIF) 32 
expressed at this time. Other genes, such as OLFM4, that may play key roles in 33 
regulating gland cell proliferation and function during the cycle were also identified. 34 
Besides the direct effect E2 and P4 have on the glands, they also exert a 35 
paracrine effect via the stromal cells. Decidualized stroma secretes a wide range of 36 
proteins, including PRL whose function is unknown. Unlike the pituitary, decidual 37 
PRL is driven from an alternative promoter, derived from transposable elements 38 
(MER20)53. Our finding that addition of PRL induces ciliated cells suggests it may 39 
influence differentiation and function of the glands during early pregnancy.  40 
The glands of gestational endometrium continue to differentiate and display a 41 
hypersecretory appearance with abundant PAEP production54, 55.  In our organoid 42 
system, addition of trophoblast hormones (hCG and hPL) resulted in a similar 43 
appearance.  This culture system will therefore allow further investigation of the 44 
essential (but understudied) period of histotrophic nutrition in the first trimester of 45 
 9 
pregnancy before the hemochorial placenta is established. Additionally, we were 1 
able to derive organoids from endometrial adenocarcinomas. These common 2 
tumours in post-menopausal women are associated with increased exposure to 3 
estrogen that is a feature of obesity, nulliparity, treatment with tamoxifen and late 4 
menopause56. These can be used in the future to build a biobank to screen drugs 5 
and investigate the mutational changes, as has been done for colon cancers57. 6 
 7 
In summary, we describe a method for reliable chemically-defined, long-term 8 
culture of endometrial glands from non-pregnant endometrium and decidua that 9 
closely recapitulates the molecular and functional characteristics of their cells of 10 
origin. The organoid cultures can be frozen down without loss of their proliferative 11 
ability upon thawing, allowing the possibility to build up patient-specific bio-banks. 12 
This method will be an invaluable research tool to study new therapies for common 13 
pathologies of the endometrium, such as endometriosis and endometrial cancer, as 14 
well as investigating problems of implantation and the secretion of uterine histotroph 15 
during early pregnancy.  16 
  17 
 10 
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Figure Legends 1 
Figure 1. Long-term 3D organoid cultures can be established from human non-2 
pregnant endometrium and decidua.  3 
 4 
(a) Scheme for deriving organoids. 5 
(b) Screening conditions for generating organoids. FGF10, A83-01, HGF and 6 
Nicotinamide added in combinations to generic organoid medium (ENR). Number 7 
of organoids derived under each condition (C2 to C9) shown relative to basal 8 
conditions (C1). Shown are decidual digests from 3 different patients. Source 9 
data in Supplementary Table 5. 10 
(c) Representative images for conditions C1-C9 in Fig. 1b. Scale bar, 500 μm.  11 
(d) Images of decidual gland isolates (passage 0) and organoids after one passage 12 
in Expansion Medium (ExM) (passage 1). Scale bar, 200 μm. Representative of 13 
all samples, summarized in Supplementary Table 1. 14 
(e) Effect of withdrawal of growth factors from ExM. Organoids grown in ExM and 15 
each factor withdrawn: EGF, Noggin (NG), Rspondin-1 (RSPO1), FGF10, A8301, 16 
HGF and Nicotinamide (NIC). Organoids formed shown relative to ExM (%). 17 
Shown are decidual cultures derived from 3 different patients. Source data in 18 
Supplementary Table 5. 19 
(f) Images of organoids established in ExM from proliferative (Prol.) endometrium 20 
(n=3), secretory (Sec.) endometrium (n=9), decidua (n=25) and post-menopausal 21 
(atrophic) endometrium (n=1). Scale bar, 100 μm.  22 
(g) IHC of decidua (in vivo) and organoids for Mucin 1 (MUC-1). Scale bar, 50 μm. 23 
Representative of 6 decidual and endometrial samples, and organoids derived 24 
from 2 endometrial and 2 decidual samples from different patients. 25 
(h) IF staining of organoid for E-CADHERIN (E-CAD) and CYTOKERATIN-7 (CK7). 26 
Scale bar, 50 μm. Experiment repeated twice (1 endometrial-derived and 1 27 
decidua-derived organoids).  28 
(i) IF staining of organoid for cell proliferation (uptake of EdU), epithelial marker 29 
EPCAM and basement membrane marker laminin (LAM). Scale bar, 50 μm. 30 
Experiment repeated twice (1 endometrial-derived and 1 decidua-derived 31 
organoids).  32 
(j) Electron micrograph (EM) of organoid showing columnar epithelial cells with 33 
basally-located nuclei. Scale bar, 5 μm. Experiment repeated twice with different 34 
donors. 35 
(k) EM showing secretory activity (black arrowheads). Scale bar, 1 μm. Experiment 36 
repeated twice with different donors. 37 
(l) PAS staining for glycogen in endometrium and organoids. Scale bars, 50 μm 38 
(main image) and 10 μm (inset). Representative of 3 endometrial samples and 3 39 
endometrial organoids. 40 
Figure 2. Established human endometrial organoids recapitulate molecular 41 
signature of glands in vivo.  42 
 43 
 15 
(a) Unsupervised hierarchical clustering analysis of global gene expression profiles 1 
by microarray of gland digests, stromal cells and corresponding established 2 
organoids from endometrium (n=7 independent donors). Analysis based on 3 
15475 probes with sd/mean >0.1. Expression profiles of organoids cluster with 4 
glands while those of the stroma cluster in a separate tree. 5 
(b) Venn diagram showing overlap of 287 genes significantly upregulated in glands 6 
and organoids with a fold change ≥1.5 (p≤0.01) relative to stroma.  7 
(c) Gene ontology (GO) analysis of the 287 genes from (b) using HumanMine v2.2 8 
database for GO Terms Biological processes and Benjamini Hochberg test 9 
correction with maximum p-value of 0.05. The top ten significantly enriched GO 10 
terms for each category are shown with the –log of their p-values and are 11 
enriched for terms describing epithelial tissue. 12 
(d) Gene ontology (GO) analysis of the 287 genes from (b) using same method as in 13 
(c). The top ten significantly enriched GO terms describe epithelial cells with 14 
secretory function. 15 
(e) Clustered heatmap of 287 genes commonly upregulated between organoids and 16 
glands compared to stroma from (b). Genes of interest are listed on the right. 17 
Epithelial markers (blue) (EPCAM, CLD10, CDH1), glandular products and 18 
markers of secretory cells (purple) (MUC20, PAX8, PAEP, MUC1), progenitor cell 19 
markers (cyan) (LRIG1, PROM1, AXIN2) and murine genes important for 20 
endometrial function (pink) (SOX17, KLF5, FOXA2).   21 
(f) IHC for genes selected from microarray, FOXA2, SOX17 and PAX8, in 22 
proliferative and secretory endometrium and organoids. Scale bars, 50 μm (main 23 
image) and 10 μm (insets). Representative of 3 proliferative and 7 secretory 24 
endometrial samples and endometrial organoids derived from 8 different patients. 25 
(g) ISH for LRIG1 on proliferative and secretory endometrium and organoids. 26 
Negative control probe is for the bacterial gene dapB. Scale bars, 50 μm (main 27 
image) and 10 μm (insets). Representative of 3 proliferative and 3 secretory 28 
endometrial samples and endometrial organoids derived from 4 different patients. 29 
Figure 3. Human endometrial organoids respond to sex hormones. 30 
 31 
(a) Ovarian hormones, Estrogen (E2)(red) and Progesterone (P4)(blue), and the 32 
cycling endometrium. Expression of Estrogen Receptor (ERα)(dashed red) and 33 
Progesterone Receptor (PR)(dashed blue) are specific for glands of the 34 
functional layer. Adapted from Reference37. 35 
(b) Protocol for hormonal stimulation. Organoids grown in ExM, day 0 (d0), are 36 
primed with E2 for 48 h on day 4 (d4) followed by stimulation with P4 and cyclic 37 
AMP (cAMP) for 48 h. 38 
(c) IHC for ERα and PR on organoids after hormonal stimulation. In ExM expression 39 
of ERα is weak, but some cells are either ERαhigh (arrowheads) or ERαnegative 40 
(arrows). Few cells are positive for PR (arrowheads). After E2 and P4 treatment, 41 
levels of ERα and PR are higher. Scale bars, 50 μm (main image) and 10 μm 42 
(insets). Representative of endometrial organoids from 6 different patients and 43 
decidual organoids from 9 different patients. 44 
 16 
(d) Clustered heatmap of selected genes from organoids grown in ExM, ExM+E2 or 1 
ExM+E2+P4+cAMP (n=3 donors). Shown are genes known to reflect 2 
differentiation in response to hormones (purple), uncharacterized genes (grey) 3 
and downregulated genes (cyan). 4 
(e) QRT-PCR analysis for differentiation markers (PAEP, SPP1, 17HSDβ2 and LIF) 5 
of organoids grown in ExM, ExM+E2 or ExM+E2+P4+cAMP. Shown is the 6 
mean±SEM levels of expression relative to housekeeping genes and ExM 7 
conditions (δδCt). Data from endometrial organoids from n=6 different patients. 8 
Source data in Supplementary Table 5. 9 
(f) Western blot for PAEP in organoids after hormonal stimulation. Levels of 10 
glycosylated and non-glycosylated PAEP increase upon exposure to E2 and 11 
E2+P4+cAMP. Ponceau S staining (Ponc S) for loading control. Experiment 12 
repeated twice using endometrial organoids from 2 patients. Unprocessed blots 13 
in Supplementary Figure 7. 14 
(g) ELISA for SPP1 production by endometrial organoids upon exposure to 15 
hormones. Three independent experiments (Donors 1-3). SPP1 secretion 16 
increases following exposure to E2 and further after E2+P4+cAMP. Source data 17 
in Supplementary Table 5. 18 
(h) IHC for OLFM4 on organoids under ExM, ExM+E2 and ExM+E2+P4+cAMP, and 19 
proliferative and secretory endometrium. Scale bars, 50 μm (main image) and 10 20 
μm (insets). Representative of 2 proliferative and 2 secretory endometrial tissues 21 
and organoids derived from 3 different patients. 22 
Figure 4. Signals from decidualised stroma and the placenta can further 23 
stimulate differentiation of human endometrial gland organoids.  24 
 25 
(a) Hormonal environment of endometrium during the first trimester of pregnancy. 26 
Estrogen (E2) and Progesterone (P4) are ovarian products, human chorionic 27 
gonadotropin (hCG) and human placental lactogen (hPL) are secreted by 28 
trophoblast and prolactin (PRL) by decidualized stromal cells. 29 
(b) Protocol for stimulation of endometrial organoids. Organoids are passaged and 30 
plated on day 0 (d0) in ExM. On d4, ExM is changed to Differentiation Medium 31 
(DM; ExM with E2+P4+cAMP). hCG, hPL and/or PRL were added for 8 d. 32 
(c) IHC for PAEP on endometrial organoids under the following conditions: ExM, DM, 33 
DM with hCG/hPL or PRL or all three combined. Maximal production of PAEP 34 
and differentiated morphology of cells is seen upon exposure to DM with hCG, 35 
hPL and PRL. Scale bar, 50 μm. Representative of endometrial organoids 36 
derived from 3 different patients. 37 
(d) IHC for acetylated α-tubulin to visualize cilia in secretory endometrium (Sec. 38 
Endom.) and endometrial organoids following stimulation with PRL. Ciliated cells 39 
(arrows) are present in the luminal epithelium (LE) and within organoids. GE, 40 
glandular epithelium. Scale bars, 50 μm (main image) and 10 μm (insets). 41 
Representative of 4 secretory endometrial samples and endometrial organoids 42 
derived from 4 different patients. 43 
 17 
(e) IHC for SOX9 on endometrial glands ex vivo and in vitro. Organoids in ExM 1 
express high levels of SOX9 similar to proliferative endometrium (Prol. Endom.). 2 
After hormonal stimulation, SOX9 is downregulated in organoids 3 
(ExM+HCG+HPL+PRL) similar to glands in decidua. Scale bars, 50 μm (main 4 
image) and 10 μm (insets). Representative of 4 proliferative endometrial samples, 5 
7 decidual samples and endometrial organoids derived from 4 different patients. 6 
 7 
Figure 5. Human endometrial organoids have clonogenic ability and are 8 
bipotent.  9 
 10 
(a) Phase-contrast images of (from top to bottom row): an organoid forming from a 11 
single cell; a single cell forming a spheroid with no further growth, and a single 12 
cell showing no growth. Images were taken every two days. Scale bar, 50 μm. 13 
Experiment was performed with 3 clonal lines derived from 2 endometrial and 1 14 
decidual organoid cultures. 15 
(b) Representative image showing expansion of a clonal culture at passage 1 (p1) 16 
from a single organoid (at passage 0, p0) in a 96-well. Scale bar, 500 μm. 12 17 
clonal cultures were established from organoids from 5 different patient samples 18 
(4 endometrial-derived and 1 decidual-derived). 19 
(c) IF on clonally-derived endometrial organoid cultures subjected to the full cocktail 20 
of hormonal stimuli to visualize two main endometrial epithelial cell types: ciliated 21 
cells (acetylated α-tubulin) (cyan) and secretory cells (PAEP) (red). Scale bars 22 
from left to right: 100 μm, 20 μm and 5 μm. Representative of 4 clonal lines 23 
derived from 2 different endometrial organoid cultures. 24 
(d) EM on clonally-derived endometrial organoid cultures subjected to the full cocktail 25 
of hormonal stimuli showing basal bodies of fully formed cilia. Scale bars: 10 μm 26 
and 1 μm. Experiment performed twice using 1 clonal endometrial organoid 27 
culture. 28 
 29 
Figure 6. Organoids can be derived from endometrial cancer.  30 
 31 
Derivation of organoids from endometrial carcinomas. From left to right: H&E stained 32 
sections of normal atrophic endometrium showing gland surrounded by dense 33 
stroma and a FIGO Grade I endometrioid carcinoma with dense glandular structures 34 
from the same patient, scale bar, 100 μm; images of organoids derived from 35 
matched normal and malignant endometrium cultured in ExM (passage 1), scale bar, 36 
100 μm; H&E stained sections showing marked differences in morphology between 37 
organoids derived from normal endometrium and those from tumours which show 38 
nuclear pleomorphism, a disorganized epithelium with irregular basement membrane 39 
and isolated cells present in surrounding Matrigel (arrows), scale bar, 20 μm; IHC for 40 
MUC-1 and SOX17 on tumour and normal organoids confirm their glandular origin, 41 
scale bar, 20 μm. Representative of organoids derived from 3 different endometrial 42 
carcinomas and 1 matching normal tissue.   43 
